Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics Revenue

Vistagen Therapeutics had revenue of $183.00K in the quarter ending September 30, 2024, a decrease of -34.17%. This brings the company's revenue in the last twelve months to $876.00K, up 8.08% year-over-year. In the fiscal year ending March 31, 2024, Vistagen Therapeutics had annual revenue of $1.06M, down -568.72%.

• Revenue (ttm): $876.00K
• Revenue Growth: +8.08%
• P/S Ratio: 89.25
• Revenue / Employee: $21,900
• Employees: 40
• Market Cap: 71.84M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	1.06M	1.29M	-568.72%
Mar 31, 2023	-227.00K	-1.34M	-120.47%
Mar 31, 2022	1.11M	19.40K	1.78%
Mar 31, 2021	1.09M	-	-
Mar 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.